Belite Bio Inc (BLTE)
48.22
-0.33
(-0.68%)
USD |
NASDAQ |
Sep 20, 16:00
48.22
0.00 (0.00%)
After-Hours: 20:00
Belite Bio Shareholders Equity (Quarterly): 114.59M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 114.59M |
March 31, 2024 | 96.47M |
December 31, 2023 | 90.43M |
September 30, 2023 | 52.79M |
June 30, 2023 | 55.72M |
Date | Value |
---|---|
March 31, 2023 | 35.17M |
December 31, 2022 | 41.50M |
June 30, 2022 | 49.63M |
December 31, 2021 | -15.09M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-15.09M
Minimum
Dec 2021
114.59M
Maximum
Jun 2024
57.91M
Average
52.79M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 24.86M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 118.43M |
Total Liabilities (Quarterly) | 3.837M |